Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 105 of the 116 references it cites were found in a registry or an index; 104 of the 282 sources its claims cite were checked for support.

Protection of the human gene research literature from contract cheating organizations known as research paper mills

Open access

Abstract

Human gene research generates new biology insights with translational potential, yet few studies have considered the health of the human gene literature. The accessibility of human genes for targeted research, combined with unreasonable publication pressures and recent developments in scholarly publishing, may have created a market for low-quality or fraudulent human gene research articles, including articles produced by contract cheating organizations known as paper mills. This review summarises the evidence that paper mills contribute to the human gene research literature at scale and outlines why targeted gene research may be particularly vulnerable to systematic research fraud. To raise awareness of targeted gene research from paper mills, we highlight features of problematic manuscripts and publications that can be detected by gene researchers and/or journal staff. As improved awareness and detection could drive the further evolution of paper mill-supported publications, we also propose changes to academic publishing to more effectively deter and correct problematic publications at scale. In summary, the threat of paper mill-supported gene research highlights the need for all researchers to approach the literature with a more critical mindset, and demand publications that are underpinned by plausible research justifications, rigorous experiments and fully transparent reporting.

Overview

CoChat Summary

TL;DR

This review argues that contract-cheating organizations known as paper mills contribute to the human gene research literature at scale and that targeted gene research is particularly vulnerable to systematic fraud. It summarizes detection features and proposes publishing changes to deter and correct problematic gene research papers.

Key findings

  • A March 2022 search identified 204 retraction notices across 36 journals (2016–2021) referring to a paper mill, undisclosed third-party use, and/or sale of article; 167/204 (81.9%) retracted papers referred to human genes in their titles, 186/204 (91.1%) were affiliated with hospitals in China, and 151/204 (74.0%) were included in mass retractions.
  • Seek & Blastn screening of over 11,700 articles, with manual verification, found 712 articles with wrongly identified nucleotide sequences across 78 journals; most of 1,535 wrongly identified sequences were claimed targeting reagents for 365 human protein-coding genes and 120 non-coding RNAs.
  • *Tumor Biology* retracted 106 articles published from 2012–2016 for manipulated peer review, and almost all (92%, 98/106) analyzed single or small groups of human genes; a further 250 retracted articles were described by Qi et al. across 19 journals.
  • Human gene research may be attractive to paper mills because targeted gene results are easy to fabricate, and many genes, biological contexts, potential authors, journals, and years enable scaled manuscript production; problematic features include implausible justifications, conserved templates, duplicated/manipulated images, wrongly identified reagents, and missing ethics or raw data.

Methods

  • Narrative review; the paper states that no new data were generated or analyzed in support of the research.
  • The authors summarize published literature and predictions about paper mills and human gene research, including prior Seek & Blastn screening results and journal editorials.
  • They also conducted a March 2022 search of literature indexed by Google Scholar and the Retraction Watch database for cancer research papers retracted due to paper mill involvement, then manually screened retraction notices for “paper mill” or references to undisclosed third-party use and/or sale of article.

Limitations

  • Stated: very little empirical research has been published about paper mills; research conducted to date has been retrospective, and some evidence is now dated; studying covert activities is difficult.
  • Stated: reasons for article retraction are not always disclosed, and the lack of corrections to many papers with identical errors could reflect barriers to post-publication correction or paper mill unwillingness to draw critical attention.
  • Evident from the text: the review’s own new empirical component is limited to a March 2022 search of cancer retractions and the Retraction Watch database, so the findings may not generalize to all human gene fields or to problematic literature that has not been retracted.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/nar/gkac1139

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. A substantial share of the biomedical literature from 1980–2020 features genes or their molecular products. (A) Percentages (Y axis) of PubMed publications per year (X axis) that feature at least one gene, according to PubTator (105). Percentages show whether publications are about humans, according to their MeSH terms (orange, about humans; blue, not about humans). (B) Percentages (Y axis) of PubMed publications per year (X axis) that are about humans, according to their MeSH terms. Percentages show publications that do/ do not feature at least one gene, according to PubTator (105) (orange, features at least one gene; blue, does not feature any gene).
Figure 1. A substantial share of the biomedical literature from 1980–2020 features genes or their molecular products. (A) Percentages (Y axis) of PubMed publications per year (X axis) that feature at least one gene, according to PubTator (105). Percentages show whether publications are about humans, according to their MeSH terms (orange, about humans; blue, not about humans). (B) Percentages (Y axis) of PubMed publications per year (X axis) that are about humans, according to their MeSH terms. Percentages show publications that do/ do not feature at least one gene, according to PubTator (105) (orange, features at least one gene; blue, does not feature any gene).CC BY · PubMed Central
Figure 2. Diagrammatic comparison of the steps required to publish genuine targeted human gene research versus those required to publish fabricated human gene research by paper mills. Most steps also pertain to gene research in other organisms, with the exception of human research ethics approval. Steps are shown in typical chronological order from left to right. Steps required for laboratory experimentation are expanded in the lower panel. Estimates of time periods required to complete each step (nil, days, weeks, months, years) by either genuine researchers or by paper mills (indicated at left) are shown above each diagram. ‘Nil’ indicates steps that do not need to be conducted by paper mills. Time estimates may not reflect the requirements of individual projects, and some steps can be undertaken simultaneously, such as obtaining regulatory approvals and purchasing equipment and/or reagents. Rate-limiting steps for genuine researchers or paper mills are highlighted in bold.
Figure 2. Diagrammatic comparison of the steps required to publish genuine targeted human gene research versus those required to publish fabricated human gene research by paper mills. Most steps also pertain to gene research in other organisms, with the exception of human research ethics approval. Steps are shown in typical chronological order from left to right. Steps required for laboratory experimentation are expanded in the lower panel. Estimates of time periods required to complete each step (nil, days, weeks, months, years) by either genuine researchers or by paper mills (indicated at left) are shown above each diagram. ‘Nil’ indicates steps that do not need to be conducted by paper mills. Time estimates may not reflect the requirements of individual projects, and some steps can be undertaken simultaneously, such as obtaining regulatory approvals and purchasing equipment and/or reagents. Rate-limiting steps for genuine researchers or paper mills are highlighted in bold.CC BY · PubMed Central
Figure 3. Scholarship distributes unevenly across genes, and knowledge gaps persist in important areas of research. (A, B) Genes are ranked (percentiles, X axis) according to the numbers of mentions in titles and abstracts, where the 100- and 0-percentiles correspond to the most/ least frequently investigated gene, respectively. (A) Cumulative share (percentages, Y axis) of all mentions of protein-coding (green) and non-coding RNA genes (brown) within titles and abstracts of PubMed publications on humans according to MESH terms. (B) Cumulative share (percentages, Y axis) of all mentions of protein-coding genes within titles and abstracts of PubMed publications on humans according to MESH terms, until the indicated years. (C) Percentages (black shading) of protein-coding genes identified by the indicated studies (106, https://agora.adknowledgeportal.org, 107) that have never appeared in the title or abstract of any publication in the relevant literature (MeSH term on Glioblastoma, MeSH term on Alzheimer's disease, LitCOVID (108)). Genes in species other than humans were mapped to their orthologs via HomoloGene. (D) Numbers of PubMed publications since 2001 (Y axis) or prior to 2001 (X axis) that mention at least one human protein-coding gene (blue dots) in the title or abstract. The year 2001 reflects the publication of the first draft of the human genome (24,25). ρ indicates Spearman's rank correlation coefficient. Protein-coding genes that are offset from the X axis have never been mentioned in any title or abstract.
Figure 3. Scholarship distributes unevenly across genes, and knowledge gaps persist in important areas of research. (A, B) Genes are ranked (percentiles, X axis) according to the numbers of mentions in titles and abstracts, where the 100- and 0-percentiles correspond to the most/ least frequently investigated gene, respectively. (A) Cumulative share (percentages, Y axis) of all mentions of protein-coding (green) and non-coding RNA genes (brown) within titles and abstracts of PubMed publications on humans according to MESH terms. (B) Cumulative share (percentages, Y axis) of all mentions of protein-coding genes within titles and abstracts of PubMed publications on humans according to MESH terms, until the indicated years. (C) Percentages (black shading) of protein-coding genes identified by the indicated studies (106, https://agora.adknowledgeportal.org, 107) that have never appeared in the title or abstract of any publication in the relevant literature (MeSH term on Glioblastoma, MeSH term on Alzheimer's disease, LitCOVID (108)). Genes in species other than humans were mapped to their orthologs via HomoloGene. (D) Numbers of PubMed publications since 2001 (Y axis) or prior to 2001 (X axis) that mention at least one human protein-coding gene (blue dots) in the title or abstract. The year 2001 reflects the publication of the first draft of the human genome (24,25). ρ indicates Spearman's rank correlation coefficient. Protein-coding genes that are offset from the X axis have never been mentioned in any title or abstract.CC BY · PubMed Central
Figure 4. Diagrammatic representation of the many topics, many authors, many journals and many years model that could scale production and publication of paper mill contributions to the human gene research literature.
Figure 4. Diagrammatic representation of the many topics, many authors, many journals and many years model that could scale production and publication of paper mill contributions to the human gene research literature.CC BY · PubMed Central

Verification

Claims the paper makes

35 Valid · 1 Not valid · 66 Not checked · 30 Own results and interpretations

79 more claims · 25 with their cited sources checked

Create a free account to see all 132 claims and to verify the 178 references still open.

See all claims — free account
  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 32

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

1 retracted

Show all 116 references

Research works printed but not linked: 2

  1. Hu, 2013, An empirical analysis on number and monetary value of ghostwritten papers in china, Curr. Sci, 105, 1230
  2. Biagioli, 2019, Introduction: metrics and the new ecologies of academic misconduct, 1

Cited by

See all 46

Metadata

Authors
Byrne, J. A., Park, Y., Richardson, R. A. K., Pathmendra, P., Sun, M., & Stoeger, T.
Affiliations
  • The University of Sydney (AU)
  • Northwestern University (US)
Corresponding author
  • Byrne, Jennifer A
  • Stoeger, Thomas
Venue
Nucleic Acids Research
Published
2022-11-28
Volume
50
Issue
21
Pages
12058-12070
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W4310956718
Cited by
46
References
116
Citations by year
2026: 10 · 2025: 11 · 2024: 13 · 2023: 10 · 2022: 2
FWCI
1.71
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Health and Medical Research Council (APP1184263)
  • Faculty of Medicine and Health, University of Sydney
  • National Science Foundation (1956338)
  • National Institutes on Aging, Integrative Multi-Scale Systems Analysis of Gene-Expression-Driven Aging Morbidity (K99AG068544)
  • National Institute of Allergy and Infectious Diseases (AI135964)
  • National Institutes of Health Training (T32GM008449)
  • Northwestern University's Biotechnology
  • University of Sydney
Topics
  • Social Sciences › Education › Academic integrity and plagiarism
  • Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
  • Social Sciences › Library and Information Sciences › Publishing and Scholarly Communication
Keywords
contract cheating, scientific fraud, publication pressure, scholarly publishing, research integrity, publication ethics, research transparency
MeSH terms
Fraud, Humans, Periodicals as Topic, Publishing, Genetic Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protection of the human gene research literature from contract cheating organizations known as research paper mills. https://app.cochat.ai/papers/10.1093/nar/gkac1139
The paper
Byrne, J. A., Park, Y., Richardson, R. A. K., Pathmendra, P., Sun, M., & Stoeger, T. (2022). Protection of the human gene research literature from contract cheating organizations known as research paper mills. Nucleic Acids Research. https://doi.org/10.1093/nar/gkac1139

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.